The first treatment registered in the ARTG AUST R 218936 for CPP1

LUCRIN DEPOT PAEDIATRIC PDS

LUCRIN Depot Paediatric 3-month 30 mg PDS injection is indicated for the treatment of central precocious puberty (CPP)1

FEATURED CONTENT

CPP Patient Kits

Lucrin support for you and
your CPP patients

AbbVie are now offering the CPP Kit, which contains a range of helpful resources for CPP patients, their carers, and the physicians that treat them.


PBS Information: Please review full product information (PI) before prescribing.

Lucrin PBS listed for treatment of Central Precocious Puberty (CPP). Treatment of CPP by or in conjunction with a paediatric endocrinologist or an endocrinologist specialising in paediatrics. Restricted benefit.

Full PI is available from AbbVie by calling 1800 043 460 or via the PI link above.

AbbreviationsARTG: Australian Register of Therapeutic Goods; CPP: Central precocious puberty.
Reference: 1. LUCRIN Depot® Paediatric Product Information.

AU-LUCR-220016 November 2022